Gut · 1988 · 64 citations · 23 references
Life SciencesImmunologyNutritional SciencesClinical ImmunologyImmunopathologyMucosal ImmunologyAutoantibodiesAutoimmune DiseasesCeliac DiseaseGastrointestinal ImmunologyMucosal ToleranceSerum Specific Immunoglobulin E TestingCeliac Disease ImmunologyCeliac Disease In AdultsCeliac Disease Nutrition TherapyCeliac Disease SerologyCeliac SerologyGluten ProteinsJejunal BiopsyVillus Height To Crypt Depth Ratio
Treatment of patients with coeliac disease with a low gluten containing diet (LGD) remains controversial. We have studied jejunal morphology and antigluten (AG) antibody titres by ELISA in patients on a LGD of 2.5-5 g/day for three to 14 months (median six months) and compared results with patients on a strict gluten free diet (GFD) for six to 27 months (median 13 months). We found no significant difference in villous height or crypt depth (eight LGD v 10 GFD patients) or serum AG-IgA, -IgG, and IgM titres (13 LGD v 12 GFD patients). there was however, a significant increase (p less than 0.05) in intra-epithelial lymphocytes in those patients on a LGD. We conclude that adult coeliac patients can tolerate a LGD without gross morphological change and without initiating significant AG antibody responses.
23
Quantitation of intraepithelial lymphocytes in human jejunum
David J. Murray · Gut · 1971 · 409 citations · Full text
Life Sciences, Immunology, Pathology +15
IgA ANTIGLIADIN ANTIBODIES: A MARKER OF MUCOSAL DAMAGE IN CHILDHOOD COELIAC DISEASE
Erkki Savilahti, Mikko Perkkiö, K. Kalimo et al. · The Lancet · 1983 · 205 citations
Alpha gliadin antibody levels: a serological test for coeliac disease.
Cliona O’Farrelly, Jacinta Kelly, W. Th. J. M. Hekkens et al. · BMJ · 1983 · 107 citations · Full text
Medicine, Immunology, Pathology +17